Wednesday, July 8, 2026

Drug profile · INN

secretin

secretin (SECRETIN-FERRING) is a secretin receptor agonist. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 1
Pipeline programs 0
News articles 0
Drug details — secretin
US status
approved
Class
Route
INJECTION
Patents
1
Programs
0
Data quality
0.84

Quick answer

secretin (SECRETIN-FERRING) is a secretin receptor agonist. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN secretin
Brand SECRETIN-FERRING
Mechanism Secretin receptor agonist
Target Secretin receptor
Route INJECTION
Formulation INJECTABLE

Mechanism of action

Secretin receptor agonist

Primary target: Secretin receptor

Approval history

Authority Status Date
FDA approved

Related & competitor drugs

  1. secretin synthetic human Secretin receptor agonist
  2. secretin synthetic porcine Secretin receptor agonist

Related patents

  1. US 11045482

    Use of glucocorticoid receptor modulators in the treatment of catecholamine-secreting tumors

    Expires Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is secretin?

secretin (SECRETIN-FERRING) is a secretin receptor agonist. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for secretin?

SECRETIN-FERRING is a marketed brand name for secretin. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of secretin?

secretin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.